...
首页> 外文期刊>Journal of Microencapsulation: Microcapsules Liposomes Nanoparticles Microcells Microspheres >Eudragit nanoparticles loaded with silybin: a detailed study of preparation, freeze-drying condition and in vitro/in vivo evaluation
【24h】

Eudragit nanoparticles loaded with silybin: a detailed study of preparation, freeze-drying condition and in vitro/in vivo evaluation

机译:装有水飞蓟宾的Eudragit纳米颗粒:制备,冻干条件和体内/体外评估的详细研究

获取原文
获取原文并翻译 | 示例
           

摘要

The objective of this work was use of silybin nanoparticles in treatment of ulcerative colitis (UC). Eudragit RL PO nanoparticles loaded with silybin were produced using solvent-evaporation emulsification technique. Then, they were coated by Eudragit FS30D. Drug release was studied in different physiological environments. Colitis was induced by 4% of acetic acid in rats which received freeze-dried nanoparticles of silybin (75 mg/kg/day), dexamethasone (1 mg/kg/day), blank nanoparticles and normal saline orally for 5 days. Then macroscopic, histopathological evaluation and biochemical analysis, including myeloperoxidase (MPO) activity, tumor necrosis factor-a (TNF-alpha) and interleukin-6 (IL-6) levels in colon tissues were determined using enzyme-linked immunosorbent assay (ELISA) kits. Macroscopic and histopathological scores were improved by the optimised nanoparticles. The optimised nanoparticles had a particle size of 109 +/- 6 nm, zeta potential of 15.4 +/- 2 mV, loading efficiency of 98.3 +/- 12% and release efficiency of 40.8 +/- 5.5% at 24 h. TNF-alpha, IL-6 and MPO activity were reduced significantly by nanoparticles compared to control group (p<0.05).
机译:这项工作的目的是使用水飞蓟宾纳米颗粒治疗溃疡性结肠炎(UC)。使用溶剂蒸发乳化技术制备了负载水飞蓟宾的Eudragit RL PO纳米颗粒。然后,将它们用Eudragit FS30D涂覆。在不同的生理环境中研究了药物释放。在大鼠中,口服4%的水飞蓟宾(75 mg / kg / day),地塞米松(1 mg / kg / day),空白纳米颗粒和生理盐水冻干的纳米颗粒诱导大鼠结肠炎5天。然后使用酶联免疫吸附测定(ELISA)确定大肠组织的宏观,组织病理学评估和生化分析,包括髓过氧化物酶(MPO)活性,肿瘤坏死因子-α(TNF-α)和白介素6(IL-6)水平。套件。优化的纳米颗粒改善了宏观和组织病理学评分。优化的纳米粒子的粒径为109 +/- 6 nm,ζ电势为15.4 +/- 2 mV,负载效率为98.3 +/- 12%,24小时释放效率为40.8 +/- 5.5%。与对照组相比,纳米颗粒可显着降低TNF-α,IL-6和MPO活性(p <0.05)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号